Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

	Three months ended March 31,
	2024						2023
	GeneDx		Legacy Sema4		Total		GeneDx		Legacy Sema4		Total
Revenue	$	61,461	$	961	$	62,422	$	40,693	$	2,446	$	43,139
Adjusted cost of services	24,099		—		24,099		26,826		2,080		28,906
Adjusted gross profit (1)	37,362		961		38,323		13,867		366		14,233
Reconciliations:
Depreciation and amortization	816		—		816		476		113		589
Stock-based compensation	48		—		48		305		(1,971)		(1,666)
Restructuring costs	48		—		48		43		31		74
Gross profit	$	36,450	$	961	$	37,411	$	13,043	$	2,193	$	15,236

(1)Adjusted cost of services and adjusted gross profit exclude depreciation and amortization expense, stock-based compensation expense and restructuring costs.